Cannabidiol (CBD) Information
1) What conditions has it been studied for?
CBD has been studied for various conditions including:
- Epilepsy and seizure disorders
- Anxiety and depression
- Chronic pain and inflammation
- Substance abuse disorders
- Neurodegenerative disorders such as Alzheimer's and Parkinson's disease
- Some types of cancer
- Sleep disorders
- Post-traumatic stress disorder (PTSD)
2) Does it work in treating those conditions?
The effectiveness of CBD varies depending on the condition. For example:
- In the treatment of epilepsy, specifically the Dravet syndrome and Lennox-Gastaut syndrome, CBD has shown to be effective and has been approved by the FDA in the form of Epidiolex.
- Studies on anxiety, depression, and sleep disorders have shown some potential benefits, but more research is needed to establish definitive conclusions.
- There is mixed evidence on CBD's effectiveness for chronic pain and inflammation, with some studies showing benefits and others indicating a need for more research.
3) What health benefits does it have?
CBD may offer various health benefits, such as:
- Reducing the frequency of seizures in certain forms of epilepsy
- Alleviating symptoms of anxiety and depression
- Potential anti-inflammatory properties
- Neuroprotective effects
- Potential to help with substance abuse treatment
- Possible improvement in sleep quality
4) Does it have any downsides?
While CBD is generally considered safe, it does have some potential downsides, including:
- Side effects like fatigue, diarrhea, and changes in appetite or weight
- Possible interactions with other medications
- Variable quality and potency among different products
- Limited regulation and oversight in the market
- Insufficient research on long-term use
5) Is it beneficial or harmful for any particular genetic variations?
Research on the relationship between genetic variations and CBD's effects is still in its infancy. Some studies suggest that:
- Genetic variations may influence how an individual metabolizes CBD, affecting its efficacy and risk of side effects.
- Specific genetic markers could predict responses to CBD treatment for certain conditions, but more research is necessary to draw concrete conclusions.
- There is no clear evidence of CBD being universally beneficial or harmful for specific genetic variations, highlighting the need for personalized medicine approaches in the future.
Research Summaries on Cannabidiol (CBD)
Labeling Accuracy of CBD Products
An evaluation of 84 CBD products purchased online revealed inconsistencies between labeled concentrations and actual content, suggesting regulation issues.
Absorption Enhancement by Lipids
Lipid co-administration significantly increases the absorption of THC and CBD, potentially enhancing therapeutic effects and toxicity.
Cannabis sativa: Uses and Bioactive Compounds
The review emphasizes the industrial and pharmaceutical significance of cannabinoids, terpenes, and phenolic compounds in Cannabis sativa.
Epidiolex for Epilepsy
CBD, marketed as Epidiolex, shows significant antiseizure effects and a good safety profile for treating Dravet and Lennox-Gastaut syndromes.
CBD for Anxiety and Sleep
Studies suggest CBD may be beneficial for treating anxiety-related disorders, with supportive evidence showing decreased anxiety and improved sleep in patients.
Dose-Response Effect of CBD on Anxiety
Research indicates that CBD's anxiolytic effect in humans follows an inverted U-shaped dose-response curve, with 300 mg doses reducing post-speech anxiety.
CBD as Antidepressant and Anxiolytic Agent
Animal model studies demonstrate the potential of CBD to alleviate symptoms of anxiety and depression, likely involving the 5-HT1A serotonin receptor.
CBD for Chronic Pain in Kidney Transplant Patients
CBD demonstrates a well-tolerated profile and potential efficacy in managing chronic pain in kidney transplant patients, with careful monitoring suggested for drug interactions.
Transdermal CBD for Arthritis
Topical CBD shows potential in providing pain relief and reducing inflammation in arthritis, highlighting a promising therapeutic avenue.
Cannabis Medicinal Extracts for Neurogenic Symptoms
Cannabis medicinal extracts improve neurogenic symptoms resistant to standard treatments, with predictable and generally manageable side effects.
CBD for Osteoarthritis Pain and Nerve Damage
Local CBD treatment may relieve osteoarthritis pain and prevent symptom progression, including nerve damage.
Acne Treatment Potential of CBD
CBD demonstrates strong sebostatic and anti-inflammatory properties, suggesting its efficacy as a treatment for acne vulgaris.
CBD as an Anticancer Drug
CBD and its analogues show promise as potential anticancer therapies, necessitating further investigation into their tumor-inhibiting properties.
Safety and Side Effects of CBD
CBD maintains a generally favorable safety profile, with a need for more research on long-term use and interactions with other drugs.
Efficacy of CBD in Epilepsy
CBD significantly reduces the frequency of seizures in Lennox-Gastaut syndrome and Dravet Syndrome, despite some adverse effects.
Lower-Risk Cannabis Use Guidelines
Updated guidelines propose evidence-based recommendations for reducing health risks associated with cannabis use.
CBD Oil Quality Assessment
Analysis of European CBD oils reveals significant discrepancies in cannabinoid content and emphasizes the need for standardized regulations.
Pharmacokinetics of Phytocannabinoids
Research establishes pharmacokinetic profiles for CBD and other cannabinoids, with implications for effective drug administration.
Medical Cannabinoids in Pediatrics
There is limited evidence supporting the use of cannabinoids for pediatric treatments, highlighting the necessity for further research.
Cannabinoids in Cancer Beyond Palliative Care
Cannabinoids, including CBD, exhibit potential as anticancer agents, although clinical applications remain to be fully explored.
Pro-tumorigenic Role of CB2 in Colon Cancer
Findings suggest that the activation of CB2 receptors could promote the progression of colon cancer, challenging its perceived anti-tumor role.
References:
- Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
- Labeling Accuracy of Cannabidiol Extracts Sold Online
- Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines
- Cannabis sativa: The Plant of the Thousand and One Molecules
- Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes
- Cannabidiol in Anxiety and Sleep: A Large Case Series
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa
- Effects of ipsapirone and cannabidiol on human experimental anxiety
- Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
- Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
- Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination
- Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
- A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
- Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
- Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
- Cannabidiol as potential anticancer drug
- An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
- Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
- TRPV1: a stress response protein in the central nervous system
- TRPV1: on the road to pain relief
- Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors
- The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling
- Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
- Lead poisoning due to adulterated marijuana in leipzig
- Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations
- A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
- Why animal studies are often poor predictors of human reactions to exposure
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- The current state and future perspectives of cannabinoids in cancer biology
- CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!
Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!